July 27, 2016
Access to comprehensive information about a medication can keep physicians informed and yield better health care decisions, argues a new set of principles from the Biotechnology Innovation Organization and the Pharmaceutical Research and Manufacturers of America. And having better-informed physicians could be good news for patients.
July 22, 2016
Patients with Alzhe.imer’s or Parkinson’s disease may have a new source of hope: cancer drugs
July 20, 2016
July 12 and 13 hearings of the FDA’s Arthritis Advisory Committee cleared the way for two new biosimilars, adalimumab and etanercept. The committee unanimously supported manufacturers’ applications for the drugs – but that wasn’t the only point of consensus. Participants and even committee members expressed concerns about unfinished regulatory policy and the need to prioritize patient safety.
July 14, 2016
A bipartisan group of U.S. senators has a question for HHS Secretary Sylvia Burwell: Any progress on the National Pain Strategy? In a letter to Secretary Burwell, 12 senators reiterate the widespread suffering and financial toll of chronic pain. “It is time,” they explain, “to transform the [National Pain Strategy] from a plan on paper to a reality …to improve [Americans’] health and quality of life.”
July 12, 2016
Breathing complications aren’t the only challenge faced by the 26 million Americans with asthma, explains a new video from the Alliance for Patient Access.
July 7, 2016
The Centers for Medicare and Medicaid Services’ Oncology Care Model is off and running. As announced during The White House’s cancer summit at Howard University, more than 200 physician practices and 3,200 oncologists have enrolled – effective July 1.
July 5, 2016
Patient advocates have teamed up to take an important message to European physicians and policymakers: distinct names for biosimilar medications are essential.
June 30, 2016
Starting July 1, patients battling hepatitis C in Delaware will have newfound access to direct-acting antiviral cures – a victory now shared with patients in New York, Pennsylvania, Florida and Washington.
June 28, 2016
The opioid abuse epidemic continues to generate state laws aimed at reducing opioid misuse and overdose.
June 23, 2016
High drug prices have led to a proliferation of value models that investigate how the United States can control ballooning health care costs. But just how realistic are these models – and their implementation?
